Pausing treatment of immunosuppressants ‘doubles response to Covid booster’

The researchers cautioned that patients should not take matters into their own hands (Jacob King/PA)

Pausing the treatment of vulnerable people on immunosuppressants doubles their antibody response to the coronavirus booster vaccination, a new study has suggested.

Researchers looked at the effect of interrupting treatment with methotrexate  – prescribed for inflammatory conditions such as rheumatoid arthritis and skin conditions such as psoriasis – for two weeks after the jab.